Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uracyst in Interstitial Cystitis/Painful Bladder Syndrome
NCT00919113Phase 2Completed
- Sponsor
- Watson Pharmaceuticals
- Start
- Jul 2009
- Primary completion
- Dec 2010
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of Uracyst in interstitial cystitis (IC), sponsored by Watson Pharmaceuticals. Started Jul 2009; status: completed.
02
Drugs
Uracyst
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT00919113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00919113.